A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy

Clinical trial NCT05581719 · TERMINATED

Trial details

NCT number: NCT05581719
Sponsor: Enlivex Therapeutics RDO Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Peritoneal Metastases Peritoneal Cancer

Start date: 2022-11-15
Primary completion: 2024-04-15
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.